Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19688992 | 0.93 | TSHR (0.48) | TSHRTDP1RAB9AALDH1A1 | |
| SCHEMBL15925795 | 0.93 | TSHR (0.66) | TSHRTDP1HPGDRAB9A | |
| SCHEMBL15933759 | 0.91 | TSHR (0.70) | TSHRTDP1 | |
| SCHEMBL22605131 | 0.91 | TSHR (0.46) | TSHRTDP1 | |
| SCHEMBL15933760 | 0.89 | TSHR (0.52) | TSHRTDP1KMT2A | |
| SCHEMBL19688993 | 0.88 | TSHR (0.52) | TSHRTDP1HPGDPOLBRAB9A | |
| SCHEMBL15925782 | 0.81 | ALDH1A1 (0.44) | TSHRALDH1A1 | |
| SCHEMBL15925781 | 0.81 | ALDH1A1 (0.46) | TSHRALDH1A1 | |
| SCHEMBL18721949 | 0.80 | TSHR (0.38) | TSHR | |
| SCHEMBL19344489 | 0.78 | TSHR (0.58) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200339846-A1 | USE OF COMPOUNDS HAVING N 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE UNITS IN TWO-COMPONENT ADHESIVES | BASF SE (DE) | 2020-10-29 | — | — | US | disclosed |
| WO-2017207461-A1 | USE OF COMPOUNDS HAVING N 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE UNITS IN TWO-COMPONENT ADHESIVES | BASF SE (DE) | 2017-12-07 | — | — | WO | disclosed |
| US-9309218-B2 | 2-Oxo-1,3-dioxolane-4-carboxamides, their preparation and use | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2016-04-12 | — | — | US | disclosed |
| US-20150051365-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2015-02-19 | — | — | US | disclosed |
| WO-2013092011-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051365-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | HAO2, OXGR1, AOX1 | TSHR 4470/4885TDP1 795/4885HPGD 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.